This is a non-promotional communication intended to facilitate transparent scientific exchange regarding developments in medical research and disease management amongst U.S. healthcare professionals. The content in the abstract and publication accessible through the buttons below includes scientific information about investigational medicines, including INBRX-106. INBRX-106 is an investigational medicine whose efficacy and safety profile have not been established. It has not been approved by the U.S. FDA or other health authority for any use.
